Can Low Frequency Mutations be Therapeutic Targets?
Yes, low frequency mutations can be potential therapeutic targets. By targeting these mutations, personalized treatment approaches can be developed to improve patient outcomes. For example, [PARP inhibitors]() have been shown to be effective in cancers with rare mutations in the BRCA genes. Additionally, ongoing research is focused on developing drugs that specifically target rare mutations, offering new avenues for treatment.
